Clinical trial
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With…
NCT00462254 · Southern California Institute for Research and Education, Other · Terminated
Key facts
| NCT number | NCT00462254 |
|---|---|
| Title | Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease |
| Official title | Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease |
| Lead sponsor | Southern California Institute for Research and Education, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | ROZEREM, Ramelteon |
| Enrollment | 4 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | Nov 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: